Emisphere Technologies, Inc. (OTCMKTS:EMIS) shares fell 1.6% on Friday . The company traded as low as $9.39 and last traded at $9.38, 16,325 shares were traded during mid-day trading. A decline of 66% from the average session volume of 47,876 shares. The stock had previously closed at $9.53.
The business has a fifty day moving average of $9.86 and a two-hundred day moving average of $8.23.
Emisphere Technologies Company Profile (OTCMKTS:EMIS)
Emisphere Technologies, Inc operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions.
See Also: Why is the price-sales ratio important?
Receive News & Ratings for Emisphere Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emisphere Technologies and related companies with MarketBeat.com's FREE daily email newsletter.